REBECCA NOLES: Open Payments
NPI 1154051571 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,651 in 169 payments from 17 companies in 2025. Trend: 2023 $2,066 · 2024 $1,902 · 2025 $3,651
Food & beverage: $3,651
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 25 | $656 |
| Madrigal Pharmaceuticals | 18 | $551 |
| ABBVIE INC. | 30 | $495 |
| Takeda Pharmaceuticals U.S.A., Inc. | 26 | $442 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $294 |
| GENZYME CORPORATION | 10 | $224 |
| QOL Medical, LLC | 7 | $201 |
| Lilly USA, LLC | 9 | $189 |
| Regeneron Healthcare Solutions, Inc. | 7 | $153 |
| Ardelyx, Inc. | 7 | $130 |
Products named: TREMFYA, REZDIFFRA, DUPIXENT, ENTYVIO, XIFAXAN, LINZESS, Sucraid, OMVOH.
Industry payments across FL — which companies pay providers there.
